Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.
2.

Effect of Intermittent versus Chronic Calorie Restriction on Tumor Incidence: A Systematic Review and Meta-Analysis of Animal Studies.

Chen Y, Ling L, Su G, Han M, Fan X, Xun P, Xu G.

Sci Rep. 2016 Sep 22;6:33739. doi: 10.1038/srep33739.

3.
4.

Caloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer.

Simone BA, Dan T, Palagani A, Jin L, Han SY, Wright C, Savage JE, Gitman R, Lim MK, Palazzo J, Mehta MP, Simone NL.

Cell Cycle. 2016 Sep;15(17):2265-74. doi: 10.1080/15384101.2016.1160982. Epub 2016 Mar 30.

5.

Obesity and cancer: mechanistic insights from transdisciplinary studies.

Allott EH, Hursting SD.

Endocr Relat Cancer. 2015 Dec;22(6):R365-86. doi: 10.1530/ERC-15-0400. Epub 2015 Sep 15. Review.

6.

Extra-prostatic transgene-associated neoplastic lesions in transgenic adenocarcinoma of the mouse prostate (TRAMP) mice.

Berman-Booty LD, Thomas-Ahner JM, Bolon B, Oglesbee MJ, Clinton SK, Kulp SK, Chen CS, La Perle KM.

Toxicol Pathol. 2015 Feb;43(2):186-97. doi: 10.1177/0192623314531351. Epub 2014 Apr 17.

7.

The protective effect of intermittent calorie restriction on mammary tumorigenesis is not compromised by consumption of a high fat diet during refeeding.

Rogozina OP, Nkhata KJ, Nagle EJ, Grande JP, Cleary MP.

Breast Cancer Res Treat. 2013 Apr;138(2):395-406. doi: 10.1007/s10549-013-2464-7. Epub 2013 Feb 28.

8.
9.

The manner in which calories are restricted impacts mammary tumor cancer prevention.

Cleary MP, Grossmann ME.

J Carcinog. 2011;10:21. doi: 10.4103/1477-3163.85181. Epub 2011 Sep 21.

10.

Weight cycling and cancer: weighing the evidence of intermittent caloric restriction and cancer risk.

Thompson HJ, McTiernan A.

Cancer Prev Res (Phila). 2011 Nov;4(11):1736-42. doi: 10.1158/1940-6207.CAPR-11-0133. Epub 2011 Oct 7. Review.

11.

Effect of chronic and intermittent calorie restriction on serum adiponectin and leptin and mammary tumorigenesis.

Rogozina OP, Bonorden MJ, Seppanen CN, Grande JP, Cleary MP.

Cancer Prev Res (Phila). 2011 Apr;4(4):568-81. doi: 10.1158/1940-6207.CAPR-10-0140. Epub 2011 Jan 21.

12.

The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women.

Harvie MN, Pegington M, Mattson MP, Frystyk J, Dillon B, Evans G, Cuzick J, Jebb SA, Martin B, Cutler RG, Son TG, Maudsley S, Carlson OD, Egan JM, Flyvbjerg A, Howell A.

Int J Obes (Lond). 2011 May;35(5):714-27. doi: 10.1038/ijo.2010.171. Epub 2010 Oct 5.

13.

"Control" laboratory rodents are metabolically morbid: why it matters.

Martin B, Ji S, Maudsley S, Mattson MP.

Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6127-33. doi: 10.1073/pnas.0912955107. Epub 2010 Mar 1.

14.

The ZEB1 transcription factor is a novel repressor of adiposity in female mice.

Saykally JN, Dogan S, Cleary MP, Sanders MM.

PLoS One. 2009 Dec 24;4(12):e8460. doi: 10.1371/journal.pone.0008460.

15.

Retinoid metabolism and ALDH1A2 (RALDH2) expression are altered in the transgenic adenocarcinoma mouse prostate model.

Touma SE, Perner S, Rubin MA, Nanus DM, Gudas LJ.

Biochem Pharmacol. 2009 Nov 1;78(9):1127-38. doi: 10.1016/j.bcp.2009.06.022. Epub 2009 Jun 21.

16.

Signal transduction molecules as targets for cancer prevention.

Bode AM, Dong Z.

Sci Signal. 2009 Feb 24;2(59):mr2. doi: 10.1126/scisignal.259mr2.

Supplemental Content

Support Center